medigraphic.com
SPANISH

Revista Cubana de Oftalmología

ISSN 1561-3070 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 1

<< Back Next >>

Rev Cub Oftal 2017; 30 (1)

Corneal changes after penetrating optical keratoplasty

Pérez PZ, Padilla GC, Jareño OM, Gómez CZ, Guerra AM, Sibila GM
Full text How to cite this article

Language: Spanish
References: 0
Page: 1-13
PDF size: 132.59 Kb.


Key words:

penetrating keratoplasty, corneal graft, transplant failure.

ABSTRACT

Objective: to determine the changes in the donor cornea after one year of keratoplasty. Methods: prospective, longitudinal and descriptive case series study conducted in 45 patients. For variable processing, the study used Yate's corrected Chi-square test associated to Wilcoxon's range test and to Fisher's exact test. Results: the most common diagnosis was bullous keratopathy (35.5 %). The annual cell loss was 22.8 %; oblique astigmatism with 61.5 % and the mean of the keratometric cylinder was 5.96 %. Using the confocal microscopy, we found lack of nervous fibers (86.7 %), presence of activated keratocytes (22.2 %) and haze (11.1 %). Transparent grafts represented 82.2 %. Activated keratocytes were observed in 80 % of non-transparent corneas. In the study, 33.3 % of corneal leukomas showed opacification. The most common complication was secondary glaucoma (33.3 %). All the bacterial corneal ulcers evolved into failed graft. Conclusions: after keratoplasty, the cornea showed annual endothelial cell loss of 22.8 %, oblique astigmatism, 3-6 diopter keratometric cylinder, presence of activated keratocytes and corneal haze as prognostic factors of loss of graft transparency. The post-ulcer corneal leukoma, bullous keratopathy as preoperative diagnosis and bacterial corneal ulcer as main complication cause loss of graft transparency.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub Oftal. 2017;30